share_log

Weapon-Maker Axon Shares Rise In Monday Pre-Market: What's Going On?

Weapon-Maker Axon Shares Rise In Monday Pre-Market: What's Going On?

武器制造商Axon的股票在周一盘前上涨:发生了什么?
Benzinga ·  12/16 19:03

Axon Enterprise Inc (NASDAQ:AXON) experienced a notable 2.81% increase in pre-market trading on Monday. This surge follows the company's inclusion in the prestigious Nasdaq-100 Index over the weekend.

Axon Enterprise Inc (纳斯达克:AXON) 在周一美股盘前交易中上涨了2.81%。这一增长是由于该公司在周末被纳入了著名的纳斯达克100指数。

The Nasdaq announced the results of its annual reconstitution of the Nasdaq-100 Index on Saturday, which saw Axon joining the ranks. This index, which was established in January 1985, serves as a crucial benchmark for non-financial companies listed on the Nasdaq. It supports a variety of financial products, including options, futures, and funds. Alongside Axon, Palantir and MicroStrategy were also added to the reorganized list.

纳斯达克于星期六宣布了其年度重组纳斯达克-100 指数的结果,Axon 成为新成员。该指数成立于1985年1月,是纳斯达克上市非金融公司的重要基准。它支持多种金融产品,包括期权、期货和所有基金类型。除了Axon外,Palantir 和 MicroStrategy 也被纳入了重组后的名单。

According to Benzinga Pro, the weapon maker has a consensus price target of $424.76, based on evaluations from 17 analysts. The highest target of $800 was set by Baird on December 6, 2024, while the lowest was $130, issued by Needham on May 11, 2022.

根据Benzinga Pro的数据,这家武器制造商的共识目标价为424.76美元,基于17位分析师的评估。最高目标价为800美元,由Baird在2024年12月6日设定,而最低目标价为130美元,由Needham在2022年5月11日发布。

The three most recent analyst ratings came from Baird, Morgan Stanley, and Northland Capital Markets, dated Dec. 6, Dec. 3, and Nov. 11, respectively. These ratings suggest an average price target of $683.33, indicating a potential 3.07% upside for Axon Enterprise Inc.

最近的三条分析师评级来自Baird、摩根士丹利和北兰资本市场,日期分别为12月6日、12月3日和11月11日。这些评级建议的平均目标价为683.33美元,显示Axon Enterprise Inc.有潜在的3.07%的上涨空间。

big
  • Dogecoin's Fate Tied To Bitcoin, Says Crypto Analyst: 'Sit Back And Wait'
  • 狗狗币的命运与比特币息息相关,分析师表示:‘坐等观望’

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

免责声明:此内容部分由Benzinga Neuro生成,并由Benzinga编辑审核和发布。

Image via Shutterstock

图片来源:shutterstock

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发